BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
13.08
0.25 (1.95%)
At close: Oct 03, 2025, 3:59 PM
13.10
0.14%
After-hours: Oct 03, 2025, 07:54 PM EDT
BriaCell Therapeutics Income Statement
Financials in USD. Fiscal
year is
August - July.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 200.93K | 178.66K | 145.96K | 114.74K | 20.62K | 20.61K | 20.6K | 20.49K | 15.4K | 15.06K | 14.75K | 14.47K | 14.47K | 14.32K | 14.17K | 14.06K | 14.06K | 9.37K | 4.69K |
Gross Profit | -27.45K | -5.18K | -10.34K | -15.53K | -20.62K | -20.61K | -20.6K | -20.49K | -15.4K | -15.06K | -14.75K | -14.47K | -14.47K | -14.32K | -14.17K | -14.06K | -14.06K | -9.37K | -4.69K |
Operating Income | -24.42M | -27.32M | -29.98M | -33.33M | -35.27M | -31.71M | -26.37M | -23.27M | -19.79M | -18.24M | -17.4M | -14.28M | -11.65M | -12.33M | -8.87M | -6.97M | -6M | -1.7M | -2.93M |
Interest Income | 86.51K | 75.49K | 110.25K | 288.02K | 496.79K | 734.67K | 977.48K | 1.04M | 910.87K | 702.97K | 393.87K | 149.56K | 127.75K | 82.2K | 66.9K | 60.59K | 28.37K | 28.33K | 28.33K |
Pretax Income | -19.64M | -11.72M | -16.72M | -4.93M | -6.1M | -12.69M | -1.37M | -8.44M | -6.02M | -7.25M | 3.92M | -22.5M | -21.46M | -12.38M | -23.55M | 3.99M | 3.16M | -298.71K | -1.72M |
Net Income | -19.43M | -11.59M | -16.6M | -4.79M | -6M | -12.61M | -13.19M | -20.3M | -17.88M | -23.01M | 37.36K | -26.39M | -29.11M | -16.15M | -27.31M | 461.26K | 3.39M | -64.23K | -1.95M |
Selling & General & Admin | 5.85M | 5.91M | 5.99M | 6.15M | 7.33M | 7.57M | 7.43M | 7.93M | 6.77M | 6.8M | 7.31M | 6.57M | 4.17M | -78.1K | -2M | -3.64M | -2.4M | -301.19K | 175.94K |
Research & Development | 18.57M | 21.41M | 23.99M | 27.18M | 27.94M | 24.14M | 18.94M | 15.34M | 13.04M | 9.18M | 6.13M | 2.88M | 6.89K | 5.36K | 96.62K | 212.37K | 212.4K | 211.29K | 1.04M |
Other Expenses | n/a | -150.75 | -295.75 | -417.75 | -988.75 | -904.97 | -823.84 | -767.23 | 1.67M | -878.43K | -878.4K | -874.51K | -2.54M | 3.8K | 7.5K | 7.2K | 5.22K | 5.22K | 1.54K |
Operating Expenses | 24.42M | 27.32M | 29.98M | 33.33M | 35.27M | 31.71M | 26.37M | 23.27M | 21.47M | 13.49M | 12.65M | 9.54M | 5.22M | 12.33M | 8.5M | 5.99M | 5.02M | 712.63K | 2.31M |
Interest Expense | 36.98K | n/a | n/a | n/a | n/a | n/a | 15.03M | 15.22M | 15.22M | 15.26M | 236.42K | 49.05K | 49.05K | 75.52K | 109.22K | 123.97K | 123.97K | 65.07K | 22.28K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.38 | 24.38 | 39.27 |
Cost & Expenses | 24.42M | 27.32M | 29.98M | 33.33M | 35.27M | 31.71M | 26.37M | 23.27M | 15.57M | 9.9M | 9.06M | 5.94M | 7.53M | 12.33M | 8.68M | 6.4M | 5.43M | 1.13M | 2.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 15.03M | 10.73M | 22.31M | 22.28M | 7.26M | 11.45M | -1.34M | 6.52M | 6.46M | 6.55M | 7.76M | -59.25K | -15.5K |
Shares Outstanding (Basic) | 1.87M | 2.7M | 1.78M | 1.2M | 1.07M | 1.07M | 1.07M | 1.07M | 1.03M | 1.03M | 1.03M | 908.00 | 1.02M | 1.05M | 1.02M | 795.00 | 316.27K | 51.46K | 51.63K |
Shares Outstanding (Diluted) | 1.87M | 2.7M | 1.78M | 1.2M | 1.07M | 1.07M | 1.11M | 1.07M | 1.03M | 1.03M | 1.03M | 1.03K | 1.02M | 1.23M | 1.02M | 795.72 | 316.27K | 51.46K | 51.63K |
EPS (Basic) | -9.83 | -4.85 | -13.26 | -4.5 | -5.79 | -12.11 | -13.05 | -19.66 | -17.81 | -22.74 | -0.58 | -27.07 | -46.83 | -27.65 | -42.61 | -22.16 | -12.74 | -32.67 | -57.86 |
EPS (Diluted) | -9.83 | -4.85 | -13.26 | -17.41 | -18.7 | -25.02 | -25.96 | -19.66 | -17.86 | -22.79 | -2.13 | -28.62 | -48.33 | -29.15 | -42.61 | -22.16 | -12.74 | -32.67 | -57.86 |
EBITDA | -24.13M | -27.19M | -29.87M | -33.25M | -29.97M | -26.41M | -21.07M | -17.97M | -31.3M | -31.75M | -16.1M | -9.81M | 3.14M | 12.28M | 928.4K | -368.25K | 1.83M | -1.88M | -3.11M |
EBIT | -24.28M | -27.32M | -29.98M | -24.84M | -22.3M | -19.7M | -14.36M | -19.75M | -32.27M | -31.77M | -16.12M | -13.72M | -768.87K | 9.06M | -2.29M | 304.57K | 2.43M | -1.77M | -3M |
Depreciation & Amortization | 163.62K | 140.78K | 108.08K | 85.24K | 16.61K | 16.62K | 16.6K | 16.6K | 16.6K | 16.6K | 16.29K | 17.27K | 17.26K | 18.13K | 17.1K | 16.12K | 16.15K | 14.51K | 15.38K |